title: Cellular and metabolic origins of flavoprotein autofluorescence in the cerebellar cortex in vivo.
abstract: Flavoprotein autofluorescence imaging, an intrinsic mitochondrial signal, has proven useful for monitoring neuronal activity. In the cerebellar cortex, parallel fiber stimulation evokes a beam-like response consisting of an initial, short-duration increase in fluorescence (on-beam light phase) followed by a longer duration decrease (on-beam dark phase). Also evoked are parasagittal bands of decreased fluorescence due to molecular layer inhibition. Previous work suggests that the on-beam light phase is due to oxidative metabolism in neurons. The present study further investigated the metabolic and cellular origins of the flavoprotein signal in vivo, testing the hypotheses that the dark phase is mediated by glia activation and the inhibitory bands reflect decreased flavoprotein oxidation and increased glycolysis in neurons. Blocking postsynaptic ionotropic and metabotropic glutamate receptors abolished the on-beam light phase and the parasagittal bands without altering the on-beam dark phase. Adding glutamate transporter blockers reduced the dark phase. Replacing glucose with lactate (or pyruvate) or adding lactate to the bathing media abolished the on-beam dark phase and reduced the inhibitory bands without affecting the light phase. Blocking monocarboxylate transporters eliminated the on-beam dark phase and increased the light phase. These results confirm that the on-beam light phase is due primarily to increased oxidative metabolism in neurons. They also show that the on-beam dark phase involves activation of glycolysis in glia resulting in the generation of lactate that is transferred to neurons. Oxidative savings in neurons contributes to the decrease in fluorescence characterizing the inhibitory bands. These findings provide strong in vivo support for the astrocyte-neuron lactate shuttle hypothesis.
authors.affiliation: Department of Neurobiology, University of Pittsburgh, Pittsburgh, PA 15261, USA.
authors.forename: Kenneth C
authors.initials: KC
authors.lastname: Reinert
authors.forename: Wangcai
authors.initials: W
authors.lastname: Gao
authors.forename: Gang
authors.initials: G
authors.lastname: Chen
authors.forename: Xinming
authors.initials: X
authors.lastname: Wang
authors.forename: Yu-Ping
authors.initials: YP
authors.lastname: Peng
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Ebner
mesh_terms: D000818:Animals; D001224:Aspartic Acid / Q000494:pharmacology; D001931:Brain Mapping; D002525:Cerebellar Cortex / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D003373:Coumaric Acids / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D005071:Evoked Potentials / Q000187:drug effects; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D005420:Flavoproteins / Q000378:metabolism*; D066298:In Vitro Techniques; D019344:Lactic Acid / Q000494:pharmacology; D051379:Mice; D008856:Microscopy, Fluorescence; D009457:Neuroglia / Q000187:drug effects / Q000378:metabolism*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*
chemical_list: D003373:Coumaric Acids; D018691:Excitatory Amino Acid Antagonists; D005420:Flavoproteins; C120673:benzyloxyaspartate; C007175:alpha-cyano-4-hydroxycinnamate; D001224:Aspartic Acid; D019344:Lactic Acid